Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://graysongvgm783083.develop-blog.com/46647745/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide